OBJECTIVE: Neonates born with NOWS may have smaller brain volumes and also have been reported to have smaller head circumferences compared to non-opioid exposed controls. There is limited data, however, comparing head measurements in neonates with NOWS versus those exposed to opioids who do not develop NOWS. The study objective was to evaluate whether opioid exposure during pregnancy was associated with an increased frequency of abnormal head measurement and whether symptomatic newborns requiring treatment had different head biometry compared to those not requiring treatment. STUDY DESIGN: We performed a retrospective cohort study of pregnant women with a singleton gestation diagnosed with opioid use disorder (OUD) and receiving buprenorphine for medicationassisted treatment (MAT) at a tertiary care academic institution from April 2015 to March 2018. We compared characteristics for newborns treated for NOWS with those not requiring medication. Data collection included head circumference (HC) at birth, demographics, illicit substances, toxicology studies, newborn gender, birth weight, and medical comorbidities. All statistical analyses were performed using SAS 9.4. RESULTS: 173 cases were included in the analysis. The incidence of NOWS was 39.9% (n¼69) in our cohort. There was no statistical significant difference in HC among neonates treated for NOWS (33.4 AE 0.3 cm) and those not treated for NOWS (33.4 AE 0.3 cm). There was no statistical difference in neonatal gender, smoking status, hypertensive disease in pregnancy, or diabetes between the two groups. Of the 173 opioid-exposed neonates, only 15 (8.7%) had a head circumference less than the 10 th percentile. CONCLUSION: Our data found neonates that develop medicationrequiring NOWS do not have a smaller head circumference as compared to opioid-exposed controls. The low incidence for low head circumference does not support the observation these neonates are at marked risk for abnormal brain volumes when enrolled in a comprehensive, multidimensional treatment program. OBJECTIVE: Interpregnancy Interval (IPI) is the time between delivery and subsequent conception. An IPI of 18-24 months is considered ideal and an IPI<18 months has been associated with adverse neonatal outcomes including preterm birth and low birth weight, however data is largely from small cohort studies or non-US populations. We sought to evaluate the association between short IPI and adverse neonatal outcomes in a large, diverse data set. STUDY DESIGN: We conducted a retrospective cohort study using vital statistics birth certificate records between 2012-2015. Women with a singleton, non-anomalous pregnancy and at least one prior live birth were included for analysis. Women were stratified by the IPI as follows: <6 months, 6-11 months, 12 months-18 months, 18-23 months and >¼24 months. Neonatal morbidity was the outcome of Poster Session II ajog.org
Interpregnancy interval and neonatal outcomes in a large US cohort
OBJECTIVE: Interpregnancy Interval (IPI) is the time between delivery and subsequent conception. An IPI of 18-24 months is considered ideal and an IPI<18 months has been associated with adverse neonatal outcomes including preterm birth and low birth weight, however data is largely from small cohort studies or non-US populations. We sought to evaluate the association between short IPI and adverse neonatal outcomes in a large, diverse data set. STUDY DESIGN: We conducted a retrospective cohort study using vital statistics birth certificate records between 2012-2015. Women with a singleton, non-anomalous pregnancy and at least one prior live birth were included for analysis. Women were stratified by the IPI as follows: <6 months, 6-11 months, 12 months-18 months, 18-23 months and >¼24 months. Neonatal morbidity was the outcome of Poster Session II interest including preterm birth, low birth weight (<2500g), very low birth weight (<1500g), NICU admission, Apgar <7, and seizures. Maternal medical conditions and socioeconomic factors known to be associated with preterm birth were evaluated and controlled for in multivariable logistic regression. RESULTS: We identified 8,013,471 women with pregnancies meeting our inclusion criteria. Of those, 1,989,686 (31.3%) had an IPI of <18 months and 516.021 (6.44%) had a very short IPI of <6 months. Short IPI was associated with preterm birth, low birth weight and very low birth weight, 5 min Apgar less than 7, NICU admission and neonatal seizures. Maternal characteristics associated with short IPI included Black, Hispanic and Native American ethnicity, limited prenatal care, tobacco use in pregnancy, and Medicaid as payer source for delivery. Diabetes and hypertensive disorder, advanced maternal age and white and Asian race/ethnicity were not associated with short IPI. When controlling for multiple potential confounding variables, short IPI remained significantly associated with preterm birth, but no other adverse neonatal outcomes. The association appears inversely proportional to the IPI with an adjusted odds ratio of 1.05 (95%CI 1.04-1.06) and 1.42 (95%CI 1.41-1.44) for IPI <18 months and <6 months respectively. CONCLUSION: In this large, diverse data set, short IPI was significantly associated with preterm birth, but was not significantly associated with other adverse neonatal outcomes.
363 Prevalence of gestational diabetes stratified by race/ethnicity is modified by place of birth OBJECTIVE: Differences in the prevalence of gestational diabetes in the US vary by maternal race/ethnicity. Our aim is to examine if the prevalence by race/ethnicity is modified by non-US place of birth. STUDY DESIGN: We conducted a retrospective cohort study using publicly available National Vital Statistics birth certificate data between 2012-2015. All singleton, non-anomalous births between 23-43 weeks' gestation were included and the following cohorts identified: white, black, Hispanic, & Asian. Records with missing or incomplete data were excluded. Women were further stratified by location of birth. The outcome of interest was prevalence of gestational diabetes. RESULTS: We identified 7,924,107 cases for inclusion of which 52.75% identified as white, 14.80% as black, 26.17% as Hispanic and 6.25% Asian. Among non-white women, being foreign born was associated with an increased risk of gestational diabetes. Among white women, being foreign born was associated with a significant decreased risk of gestational diabetes (image 1, all p value <0.001). When controlling for maternal race and body mass index, being foreign born remained protective among white women (aOR 0.97, 95%CI 0.97-0.98) and, conversely, remained associated with increased risk of developing gestational diabetes among non white women the adjusted odds ratio ranging from 1.13 (95%CI 1.11-1.15) for black women to 1.28 (95%CI 1.27-1.30) for Asian women. CONCLUSION: This study suggests that location of birth may have a modifying impact on risk of gestational diabetes that varies by maternal race/ethnicity. Such findings suggest a possible epigenetic role in the predisposition for gestational diabetes. Further study is warranted.
364 Quantitative blood loss during delayed cord clamping at cesarean delivery: A prospective case series Rebecca M. Reimers, Daniela Carusi, Michaela Farber, James Greenberg
Brigham and Women's Hospital, Boston, MA OBJECTIVE: Delayed umbilical cord clamping for 30 to 60 seconds after hysterotomy during cesarean section has been recommended by the American College of Obstetrics and Gynecology since January of 2017. However, there is no data that objectively quantifies blood loss attributable to delayed cord clamping at cesarean delivery. This study aims to quantify the amount of blood lost during cesarean per minute of delayed cord clamping. STUDY DESIGN: This is a prospective case series at an academic medical center from 1/2018 to 4/2018. Women with a singleton pregnancy, planned cesarean at 37 0/7 weeks or greater, and plan for routine delayed cord clamping were included. Those with a placenta previa or accreta, coagulopathy, or urgent or emergent cesarean delivery were excluded. Blood loss during delayed cord clamping was quantified by clearing the field of fluids after delivery and collecting blood from the hysterotomy with a laparotomy sponge. The blood soaked sponges were then weighed and the weight of the dry materials subtracted. This study was IRB approved. RESULTS: There were 20 patients included for analysis. The mean time of collection was 47 seconds (SD 10.2) and the mean blood collected during delayed cord clamping was 110.8 mL (SD 53.4 mL). The blood loss per patient was standardized to one minute (blood volume x [60/collection time]) and the median blood loss in one minute was 150 mL (IQR 88.8 mL, 95% CI 109.2-190.4 mL). Eight participants had a cesarean delivery in labor, one had an extension of the hysterotomy, the mean post-operative hematocrit drop was 4.4%, and there were no blood transfusions. Uterine extension was the most significant cofactor in linear regression to with dependent variable of blood loss per minute (p¼0.002). With a uterine extension there was a loss of 413 mL per minute of blood. CONCLUSION: Our pilot study suggests that delayed cord clamping without hysterotomy extension is associated with a mean blood loss of 150 mL/min. If there is an associated hysterotomy extension into the uterine vasculature, maternal blood loss per minute may be more clinically concerning at 413 ml/minute. If delayed cord clamping is adopted on a routine basis, the hysterotomy should be examined and extensions may be an indication to minimize or cease delayed cord clamping, particularly in patients with pre-existing anemia.
